Bioaffinity Technologies, Stock Market Value
| BIAF Stock | USD 1.22 0.02 1.61% |
| Symbol | BioAffinity |
bioAffinity Technologies, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies,. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share 0.744 | Quarterly Revenue Growth 120.474 | Return On Assets (0.70) | Return On Equity (1.52) |
The market value of bioAffinity Technologies, is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies,'s value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies,'s market value can be influenced by many factors that don't directly affect BioAffinity Technologies,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioAffinity Technologies, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAffinity Technologies,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAffinity Technologies,.
| 02/04/2023 |
| 11/25/2024 |
If you would invest 0.00 in BioAffinity Technologies, on February 4, 2023 and sell it all today you would earn a total of 0.00 from holding bioAffinity Technologies, or generate 0.0% return on investment in BioAffinity Technologies, over 660 days. BioAffinity Technologies, is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targete... More
BioAffinity Technologies, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAffinity Technologies,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess bioAffinity Technologies, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 61.86 | |||
| Value At Risk | (7.33) | |||
| Potential Upside | 10.1 |
BioAffinity Technologies, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAffinity Technologies,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAffinity Technologies,'s standard deviation. In reality, there are many statistical measures that can use BioAffinity Technologies, historical prices to predict the future BioAffinity Technologies,'s volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (1.40) | |||
| Treynor Ratio | (0.33) |
bioAffinity Technologies, Backtested Returns
bioAffinity Technologies, secures Sharpe Ratio (or Efficiency) of -0.0241, which signifies that the company had a -0.0241% return per unit of risk over the last 3 months. bioAffinity Technologies, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioAffinity Technologies,'s Standard Deviation of 7.08, risk adjusted performance of (0.02), and Coefficient Of Variation of (2,579) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.85, which signifies possible diversification benefits within a given portfolio. BioAffinity Technologies, returns are very sensitive to returns on the market. As the market goes up or down, BioAffinity Technologies, is expected to follow. At this point, bioAffinity Technologies, has a negative expected return of -0.17%. Please make sure to confirm BioAffinity Technologies,'s skewness, rate of daily change, and the relationship between the value at risk and accumulation distribution , to decide if bioAffinity Technologies, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.35 |
Below average predictability
bioAffinity Technologies, has below average predictability. Overlapping area represents the amount of predictability between BioAffinity Technologies, time series from 4th of February 2023 to 31st of December 2023 and 31st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of bioAffinity Technologies, price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current BioAffinity Technologies, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
bioAffinity Technologies, lagged returns against current returns
Autocorrelation, which is BioAffinity Technologies, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioAffinity Technologies,'s stock expected returns. We can calculate the autocorrelation of BioAffinity Technologies, returns to help us make a trade decision. For example, suppose you find that BioAffinity Technologies, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioAffinity Technologies, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioAffinity Technologies, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioAffinity Technologies, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioAffinity Technologies, stock over time.
Current vs Lagged Prices |
| Timeline |
BioAffinity Technologies, Lagged Returns
When evaluating BioAffinity Technologies,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioAffinity Technologies, stock have on its future price. BioAffinity Technologies, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioAffinity Technologies, autocorrelation shows the relationship between BioAffinity Technologies, stock current value and its past values and can show if there is a momentum factor associated with investing in bioAffinity Technologies,.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether bioAffinity Technologies, is a strong investment it is important to analyze BioAffinity Technologies,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BioAffinity Technologies,'s future performance. For an informed investment choice regarding BioAffinity Stock, refer to the following important reports:Check out BioAffinity Technologies, Correlation, BioAffinity Technologies, Volatility and BioAffinity Technologies, Alpha and Beta module to complement your research on BioAffinity Technologies,. For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
BioAffinity Technologies, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.